Prognostic score of gastric cancer determined by cDNA microarray

Hiroshi Inoue, Ayumi Matsuyama, Koshi Mimori, Hiroaki Ueo, Masaki Mori

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Purpose: To estimate gastric cancer patients' prognosis more comprehensively, we tried to develop a prognostic scoring system using a cDNA microarray. Experimental Design: RNA was extracted from tumor/normal paired samples of 43 patients with gastric cancer, and cDNA microarray hybridization was performed. Results: We selected 78 genes that were differentially expressed between aggressive and nonaggressive groups with respect to five conventional pathological factors. Next, we determined a coefficient for each gene. Thereafter a prognostic score was calculated by summing-up the value for each gene. It ranged from -47 to 201 with a median of 114. There were two peaks in its distribution. Ten of 11 patients who were alive with no evidence of recurrence >5 years after the operation showed a score of <100 points, whereas all 19 patients who died of disease showed >100 points. In 13 patients who were alive but the follow-up time was <5 years, 2 of the 3 patients with >100 points revealed recurrent disease during the follow-up. Conclusions: These findings demonstrate that such a system with cDNA microarray can contribute to the comprehensive analysis of malignant behavior of the tumor and may provide accurate information on prognosis.

Original languageEnglish
Pages (from-to)3475-3479
Number of pages5
JournalClinical Cancer Research
Volume8
Issue number11
Publication statusPublished - Nov 1 2002

Fingerprint

Oligonucleotide Array Sequence Analysis
Stomach Neoplasms
Genes
Neoplasms
Research Design
RNA
Recurrence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Prognostic score of gastric cancer determined by cDNA microarray. / Inoue, Hiroshi; Matsuyama, Ayumi; Mimori, Koshi; Ueo, Hiroaki; Mori, Masaki.

In: Clinical Cancer Research, Vol. 8, No. 11, 01.11.2002, p. 3475-3479.

Research output: Contribution to journalArticle

Inoue, H, Matsuyama, A, Mimori, K, Ueo, H & Mori, M 2002, 'Prognostic score of gastric cancer determined by cDNA microarray', Clinical Cancer Research, vol. 8, no. 11, pp. 3475-3479.
Inoue, Hiroshi ; Matsuyama, Ayumi ; Mimori, Koshi ; Ueo, Hiroaki ; Mori, Masaki. / Prognostic score of gastric cancer determined by cDNA microarray. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 11. pp. 3475-3479.
@article{19b2467472654f06be385a30f5fe89d0,
title = "Prognostic score of gastric cancer determined by cDNA microarray",
abstract = "Purpose: To estimate gastric cancer patients' prognosis more comprehensively, we tried to develop a prognostic scoring system using a cDNA microarray. Experimental Design: RNA was extracted from tumor/normal paired samples of 43 patients with gastric cancer, and cDNA microarray hybridization was performed. Results: We selected 78 genes that were differentially expressed between aggressive and nonaggressive groups with respect to five conventional pathological factors. Next, we determined a coefficient for each gene. Thereafter a prognostic score was calculated by summing-up the value for each gene. It ranged from -47 to 201 with a median of 114. There were two peaks in its distribution. Ten of 11 patients who were alive with no evidence of recurrence >5 years after the operation showed a score of <100 points, whereas all 19 patients who died of disease showed >100 points. In 13 patients who were alive but the follow-up time was <5 years, 2 of the 3 patients with >100 points revealed recurrent disease during the follow-up. Conclusions: These findings demonstrate that such a system with cDNA microarray can contribute to the comprehensive analysis of malignant behavior of the tumor and may provide accurate information on prognosis.",
author = "Hiroshi Inoue and Ayumi Matsuyama and Koshi Mimori and Hiroaki Ueo and Masaki Mori",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "8",
pages = "3475--3479",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Prognostic score of gastric cancer determined by cDNA microarray

AU - Inoue, Hiroshi

AU - Matsuyama, Ayumi

AU - Mimori, Koshi

AU - Ueo, Hiroaki

AU - Mori, Masaki

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Purpose: To estimate gastric cancer patients' prognosis more comprehensively, we tried to develop a prognostic scoring system using a cDNA microarray. Experimental Design: RNA was extracted from tumor/normal paired samples of 43 patients with gastric cancer, and cDNA microarray hybridization was performed. Results: We selected 78 genes that were differentially expressed between aggressive and nonaggressive groups with respect to five conventional pathological factors. Next, we determined a coefficient for each gene. Thereafter a prognostic score was calculated by summing-up the value for each gene. It ranged from -47 to 201 with a median of 114. There were two peaks in its distribution. Ten of 11 patients who were alive with no evidence of recurrence >5 years after the operation showed a score of <100 points, whereas all 19 patients who died of disease showed >100 points. In 13 patients who were alive but the follow-up time was <5 years, 2 of the 3 patients with >100 points revealed recurrent disease during the follow-up. Conclusions: These findings demonstrate that such a system with cDNA microarray can contribute to the comprehensive analysis of malignant behavior of the tumor and may provide accurate information on prognosis.

AB - Purpose: To estimate gastric cancer patients' prognosis more comprehensively, we tried to develop a prognostic scoring system using a cDNA microarray. Experimental Design: RNA was extracted from tumor/normal paired samples of 43 patients with gastric cancer, and cDNA microarray hybridization was performed. Results: We selected 78 genes that were differentially expressed between aggressive and nonaggressive groups with respect to five conventional pathological factors. Next, we determined a coefficient for each gene. Thereafter a prognostic score was calculated by summing-up the value for each gene. It ranged from -47 to 201 with a median of 114. There were two peaks in its distribution. Ten of 11 patients who were alive with no evidence of recurrence >5 years after the operation showed a score of <100 points, whereas all 19 patients who died of disease showed >100 points. In 13 patients who were alive but the follow-up time was <5 years, 2 of the 3 patients with >100 points revealed recurrent disease during the follow-up. Conclusions: These findings demonstrate that such a system with cDNA microarray can contribute to the comprehensive analysis of malignant behavior of the tumor and may provide accurate information on prognosis.

UR - http://www.scopus.com/inward/record.url?scp=0036850147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036850147&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 3475

EP - 3479

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 11

ER -